ASLN Stock Summary and Trading Ideas (Aslan Pharmaceuticals Limited - American Depositary Shares | NASDAQ:ASLN)

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease. The Company's major business is research and development and operates only in one single segment.

Aslan Pharmaceuticals Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol ASLN.

As of April 19, 2024, ASLN stock price declined to $0.51 with 24,383 million shares trading.

ASLN has a beta of 2.30, meaning it tends to be more sensitive to market movements. ASLN has a correlation of 0.03 to the broad based SPY ETF.

ASLN has a market cap of $11.58 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ASLN stock traded as high as $96.75 and as low as $.39.

The top ETF exchange traded funds that ASLN belongs to (by Net Assets): SPEM.

ASLN has underperformed the market in the last year with a return of -86.2%, while the SPY ETF gained +21.2%. In the last 3 month period, ASLN fell short of the market, returning -3.3%, while SPY returned +4.3%. However, in the most recent 2 weeks ASLN has outperformed the stock market by returning +0.4%, while SPY returned -3.5%.

ASLN support price is $.50 and resistance is $.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASLN stock will trade within this expected range on the day.